Resound Vivia 9 60S microRIE vs Sennheiser All Day Clear

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.

The Sennheiser All Day Clear is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.4/5, placing it in the top 8% of the OTC category and ranking #6 among 65 tested devices. At $949, this behind-the-ear device delivers strong overall performance that stands out in a crowded market. In our lab testing, the All Day Clear excels in speech clarity for quiet environments, scoring 4.0/5—a strong result that sits 1.25 points above the category average. Music streaming quality is another highlight, with a solid 3.3/5 score that's 1.38 points above average, making it one of the better choices for users who value audio fidelity beyond speech. Feedback handling is excellent at 5.0/5, meaning users should experience minimal whistling issues. The device shows more modest performance in challenging listening situations. Speech in noise scores 1.9/5, which is above the category average by 0.39 points but low in absolute terms—a common limitation across OTC devices. Own voice comfort is mixed at 2.5/5, essentially matching the category average. Best for: Consumers seeking a reliable OTC option with strong speech clarity in everyday quiet-to-moderate environments and quality music streaming. Those frequently in noisy settings may find the speech-in-noise performance limiting, though this reflects broader OTC category constraints rather than a specific weakness of this device.